{
  "trial_id": "NCT01501487",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Women with histologically proven invasive breast cancer and no distant metastases and;",
      "label": "met"
    },
    {
      "criterion": "Lymphnode negative and a clinical tumor classification of T2 (\u22653.5cm)-T4 or with 1-3",
      "label": "met"
    },
    {
      "criterion": "positive lymph nodes and a clinical tumor classification of T2-T4 DCIS or LCIS are",
      "label": "met"
    },
    {
      "criterion": "allowed in addition to invasive cancer at T2 or T3 level.",
      "label": "unknown"
    },
    {
      "criterion": "Age \u2265 18 years.",
      "label": "met"
    },
    {
      "criterion": "At least one lesion that can be accurately measured in two dimensions utilizing",
      "label": "met"
    },
    {
      "criterion": "mammogram, ultrasound, or MRI images to define specific size and validate complete",
      "label": "unknown"
    },
    {
      "criterion": "pathologic response.",
      "label": "unknown"
    },
    {
      "criterion": "Adequate bone marrow reserves (neutrophil count >1.5 x109 /l and platelet count >100",
      "label": "met"
    },
    {
      "criterion": "x109/l), adequate renal function (serum creatinine \u2264 1.5 x upper limit of normal) and",
      "label": "unknown"
    },
    {
      "criterion": "hepatic function (ALAT, ASAT \u2264 2.5 x upper limit of normal, alkaline phosphatase \u2264 2.5",
      "label": "met"
    },
    {
      "criterion": "x upper limit of normal and total bilirubin \u2264 2.0 x upper limit of normal).",
      "label": "unknown"
    },
    {
      "criterion": "Signed informed consent of the patient",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Any patient with confirmed metastatic disease.",
      "label": "not_met"
    },
    {
      "criterion": "Patients with inflammatory breast cancer.",
      "label": "not_met"
    },
    {
      "criterion": "Tumor sample shipped to Agendia with \u2264 30% tumor cells or that fails Quality Assurance",
      "label": "unknown"
    },
    {
      "criterion": "or Quality Control criteria.",
      "label": "unknown"
    },
    {
      "criterion": "Patients who have had any prior chemotherapy, radiotherapy, or endocrine therapy for",
      "label": "not_met"
    },
    {
      "criterion": "the treatment of breast cancer.",
      "label": "unknown"
    },
    {
      "criterion": "Any serious uncontrolled intercurrent infections, or other serious uncontrolled",
      "label": "unknown"
    },
    {
      "criterion": "concomitant disease.",
      "label": "unknown"
    }
  ],
  "notes": "45-year-old postmenopausal woman with cytologically confirmed breast cancer. No distant metastases.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT01501487",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}